Nasdaq: PALI

Palisade Bio, Inc. (PALI)

Palisade Bio, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker PALI. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
PALI
Exchange
Nasdaq
SEC CIK
1357459
Official filings
SEC EDGAR

Research PALI

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Palisade Bio, Inc.'s stock ticker?

Palisade Bio, Inc. trades under the ticker symbol PALI on Nasdaq. Its SEC Central Index Key (CIK) is 1357459.

Where can I read Palisade Bio, Inc.'s SEC filings?

The PALI SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Palisade Bio, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze PALI's financial statements?

The PALI Financials page shows Palisade Bio, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does PALI compare with its peers and the market?

The PALI Peer Comparison page lines Palisade Bio, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.